[1]
C. Pivadga, E. P. Odum, și B. A. A.- Hart, „Hydroxyurea Dose Escalation to Maximum Tolerated Dose in Pediatric Sickle Cell Disease: Hematologic and Clinical Outcomes in a Resource-Limited Setting in Cameroon. A Quasi-Experimental Study”., SJHR-Africa, vol. 7, nr. 3, p. 10, mar. 2026, doi: 10.51168/6zd3jy11.